These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 23413283)
1. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis. Usategui A; Criado G; Izquierdo E; Del Rey MJ; Carreira PE; Ortiz P; Leonard WJ; Pablos JL Ann Rheum Dis; 2013 Dec; 72(12):2018-23. PubMed ID: 23413283 [TBL] [Abstract][Full Text] [Related]
3. Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor β. Christmann RB; Mathes A; Affandi AJ; Padilla C; Nazari B; Bujor AM; Stifano G; Lafyatis R Arthritis Rheum; 2013 May; 65(5):1335-46. PubMed ID: 23335246 [TBL] [Abstract][Full Text] [Related]
4. Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma. Usategui A; Criado G; Del Rey MJ; Faré R; Pablos JL Arch Dermatol Res; 2014 Oct; 306(8):757-61. PubMed ID: 24788893 [TBL] [Abstract][Full Text] [Related]
5. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
6. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis. Wang C; Oishi K; Kobayashi T; Fujii K; Horii M; Fushida N; Kitano T; Maeda S; Ikawa Y; Komuro A; Hamaguchi Y; Matsushita T Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892317 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis. Bhattacharyya S; Wang W; Tamaki Z; Shi B; Yeldandi A; Tsukimi Y; Yamasaki M; Varga J Front Immunol; 2018; 9():2434. PubMed ID: 30405628 [TBL] [Abstract][Full Text] [Related]
9. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease. Datta A; Alexander R; Sulikowski MG; Nicholson AG; Maher TM; Scotton CJ; Chambers RC J Immunol; 2013 Nov; 191(9):4867-79. PubMed ID: 24081992 [TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts. Agarwal SK; Wu M; Livingston CK; Parks DH; Mayes MD; Arnett FC; Tan FK Arthritis Res Ther; 2011 Jan; 13(1):R3. PubMed ID: 21223583 [TBL] [Abstract][Full Text] [Related]
12. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis. Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144 [TBL] [Abstract][Full Text] [Related]
13. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis. Lei L; He ZY; Zhao C; Sun XJ; Zhong XN Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages. Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630 [TBL] [Abstract][Full Text] [Related]
16. Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps. Liao B; Cao PP; Zeng M; Zhen Z; Wang H; Zhang YN; Hu CY; Ma J; Li ZY; Song J; Liu JX; Peng LY; Liu Y; Ning Q; Liu Z Allergy; 2015 Sep; 70(9):1169-80. PubMed ID: 26095319 [TBL] [Abstract][Full Text] [Related]
17. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. Nagarkar DR; Poposki JA; Tan BK; Comeau MR; Peters AT; Hulse KE; Suh LA; Norton J; Harris KE; Grammer LC; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A J Allergy Clin Immunol; 2013 Sep; 132(3):593-600.e12. PubMed ID: 23688414 [TBL] [Abstract][Full Text] [Related]
18. Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response. Jessup HK; Brewer AW; Omori M; Rickel EA; Budelsky AL; Yoon BR; Ziegler SF; Comeau MR J Immunol; 2008 Sep; 181(6):4311-9. PubMed ID: 18768889 [TBL] [Abstract][Full Text] [Related]